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Abstract  A  high  percentage  of  patients  relapse  within  months  following  an  attempt  to  quit
smoking.  For  this  reason,  greater  understanding  of  the  determinants  of  successful  smoking
cessation is  needed.  The  present  study  assessed  the  effect  of  Contingency  Management  (CM)
combined with  Cognitive-Behavioral  Treatment  (CBT)  on  certain  in-treatment  behaviors  (treat-
ment retention,  in-treatment  smoking  abstinence,  and  weekly  decrease  of  cotinine  levels)  and
examined the  effects  of  these  in-treatment  behaviors  on  smoking  status  at  a  6-month  follow-
up. A  total  of  154  treatment-seeking  patients  in  a  community  setting  were  randomly  assigned
to a  CBT,  CBT  plus  CM  for  Abstinence  (CMA)  or  to  a  CBT  plus  CM  for  Shaping  cessation  (CMS)
group. Both  CBT  +  CM  procedures  improved  the  in-treatment  behaviors  compared  to  CBT  alone.
These in-treatment  behaviors  (particularly  in-treatment  smoking  abstinence)  were  associated
with long-term  abstinence.  The  effect  of  CM  on  in-treatment  behaviors  may  partially  explain
the positive  long-term  outcomes  of  this  procedure.  Our  ﬁndings  extend  previous  knowledge
about the  effect  of  CM  on  smoking  behavior.
© 2015  Asociación  Espan˜ola  de  Psicología  Conductual.  Published  by  Elsevier  España,  S.L.U.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
PALABRAS  CLAVE
Fumar;
manejo  de
El  manejo  de  contingencias  mediante  incentivos  y  las  conductas  intra-tratamiento  en
una  intervención  para  dejar  de  fumarcontingencias;
conductas
Resumen  Un  alto  porcentaje  de  pacientes  recae  en  cuestión  de  meses  después  de  un  intento
para dejar  de  fumar.  Por  esta  razón,  es  necesaria  una  mayor  comprensión  de  los  determi-intra-tratamiento;
estudio  experimental
nantes del  éxito  para  dejar  de  fumar.  Este  estudio  evaluó  el  efecto  del  Manejo  de  Contingencias
(MC) combinado  con  un  Tratamiento  Cognitivo-Conductual  (TCC)  sobre  ciertas  conductas  intra-
tratamiento  (tasas  de  retención,  abstinencia  durante  el  tratamiento  y  reducción  semanal  de
los niveles  de  cotinina)  y  examinó  los  efectos  de  estas  conductas  sobre  el  consumo  de  tabaco  a
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he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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los  6  meses  de  seguimiento.  Un  total  de  154  pacientes  que  buscaban  tratamiento  en  un  entorno
comunitario  fueron  asignados  aleatoriamente  a  TCC,  TCC  más  MC  para  Abstinencia  (MCA)  o  TCC
más MC  con  Moldeamiento  (MCM).  Ambos  procedimientos  de  TCC  +  MC  mejoraron  las  conductas
intra-tratamiento  en  comparación  con  TCC  solo.  Estas  conductas  (particularmente  abstinencia
durante el  tratamiento)  se  asociaron  con  la  abstinencia  a  largo  plazo.  El  efecto  del  MC  sobre  las
conductas intra-tratamiento  puede  explicar  parcialmente  los  resultados  positivos  a  largo  plazo
de este  procedimiento.  Nuestros  hallazgos  amplían  el  conocimiento  previo  acerca  del  efecto
del MC  sobre  la  conducta  de  fumar.
© 2015  Asociación  Espan˜ola  de  Psicología  Conductual.  Publicado  por  Elsevier  España,  S.L.U.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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eTobacco  smoking  continues  to  be  the  health  problem
that  causes  more  mortality  and  morbidity  in  Spain  (Díaz-
Gete  et  al.,  2013)  and  appears  to  be  negatively  associated
with  quality  of  life  (Becon˜a et  al.,  2013).  Despite  signiﬁcant
progress  being  made  in  the  ﬁeld  of  smoking  cessation  treat-
ments,  a  high  percentage  of  patients  relapse  within  months
of  a  quit  attempt  (García-Rodríguez  et  al.,  2013),  so  more
effective  intervention  strategies  containing  speciﬁc  long-
term  relapse  prevention  components  are  needed  (Alessi,
Petry,  &  Urso,  2008).  In  addition,  identifying  the  predictors
of  long-term  success  is  essential  for  improving  treatments
for  smoking  cessation.
Certain  individual  and  environmental  factors  moderate
both  long-term  abstinence  and  relapse  in  patients  who  have
received  treatment  for  smoking  cessation.  Being  male  or
having  received  a  higher  level  of  education  usually  increases
the  likelihood  of  quitting  (Dorner,  Troestl,  Womastek,  &
Groman,  2011;  Ferguson  et  al.,  2003;  Higgins  et  al.,  2009).
Later  initiation,  lower  nicotine  dependence,  a  longer  dura-
tion  of  prior  abstinence  and  a  higher  stage  of  change  are
also  related  to  better  long-term  outcomes  (Dorner  et  al.,
2011;  Ferguson  et  al.,  2003).  Conversely,  some  factors  are
related  to  a  lower  likelihood  of  quitting,  such  as  illicit  sub-
stance  use  (Winhusen  et  al.,  2014),  having  a  social  and
family  smoking  context  (García-Rodríguez,  Suárez-Vázquez,
Santonja-Gómez,  Secades-Villa,  &  Sánchez-Hervás,  2011)  or
some  psychopathological  factors,  such  as  previous  history
of  depression  or  schizotypal  personality  (Burch  &  Hemsley,
2008;  Dorner  et  al.,  2011).
In-treatment  variables  have  also  been  identiﬁed  as
predictors  of  long-term  abstinence.  Previous  research
has  shown  that  prior  smoking  abstinence  during  treat-
ment  can  directly  inﬂuence  subsequent  efforts  to  abstain
from  smoking  (Heil,  Alessi,  Lussier,  Badger,  &  Higgins,  2004),
suggesting  that  smoking  treatment  programs  could  be  opti-
mized  by  targeting  this  speciﬁc  behavior  (Romanowich
&  Lamb,  2010b).  Furthermore,  consecutive  abstinence
throughout  and  at  end-of-treatment,  and  attending  more
sessions  during  the  treatment  are  factors  commonly  related
to  a  higher  chance  of  success  in  quitting  (Dorner  et  al.,
2011;  Romanowich  &  Lamb,  2010b).  Other  variables  such  as
monitoring  participants’  behavior  (e.g.,  the  proportion  of
negative  samples  submitted  or  attendance  during  the  treat-
ment),  or  the  use  of  biochemical  tests  to  verify  abstinence,
e
p
elso  increase  the  likelihood  of  success  (McPherson,  Packer,
ameron,  Howell,  &  Roll,  2014;  Petry,  Alessi,  &  Ledgerwood,
012).
One  of  the  most  efﬁcacious  treatment  modalities
or  the  treatment  of  addictive  behaviors  related  to
 wide  range  of  drugs,  including  tobacco,  is  Contin-
ency  Management  (CM),  an  approach  that  typically
nvolves  rewards  contingent  upon  objective  veriﬁcation
f  self-reported  status  (Fernández-Artamendi,  Fernández-
ermida,  Godley,  &  Secades-Villa,  2014;  Higgins,  Silverman,
 Heil,  2008;  Secades-Villa,  García-Rodríguez,  López-
ún˜ez,  Alonso-Pérez,  &  Fernández-Hermida,  2014;  Sigmon  &
atrick,  2012).  This  empirically-supported  behavioral  treat-
ent  is  based  on  the  principle  of  operant  conditioning,
uggesting  that  substance-use  behavior  occurs  within  the
ontext  of  environmental  contingencies  that  make  it  more
r  less  likely  to  occur  (Higgins  et  al.,  2008).
Although  long-term  smoking  abstinence  is  the  intended
utcome  of  CM  interventions  (Higgins  et  al.,  2006;  Lamb,
orral,  Kirby,  Iguchi,  &  Galbicka,  2004),  some  studies  have
sed  incentives  for  improving  in-treatment  behaviors.  These
tudies  have  shown  that  CM  procedures  improve  both  smok-
ng  reduction  and  abstinence  during  the  treatment  (Alessi,
adger,  &  Higgins,  2004;  Alessi  et  al.,  2008;  Chivers,  Higgins,
eil,  Proskin,  &  Thomas,  2008;  Dunn,  Sigmon,  Thomas,
eil,  &  Higgins,  2008;  Higgins  et  al.,  2004;  Higgins  et  al.,
012;  Lamb  et  al.,  2007;  Lussier,  Higgins,  &  Badger,  2005;
omanowich  &  Lamb,  2010a;  Tidey,  Rohsenow,  Kaplan,
wift,  &  Reid,  2011).  CM  has  been  shown  to  reduce  carbon
onoxide  levels  (Dallery,  Raiff,  &  Grabinski,  2013)  and  to
nhance  early  abstinence  during  the  treatment  (Heil  et  al.,
004;  Higgins  et  al.,  2006;  Lamb  et  al.,  2004;  Romanowich  &
amb,  2010b;  Yoon,  Higgins,  Bradstreet,  Badger,  &  Thomas,
009).  The  CM  procedure  is  also  associated  with  signiﬁcantly
igher  rates  of  treatment  completion  (Volpp  et  al.,  2006).
Despite  previous  knowledge,  important  questions  remain
bout  the  effect  of  CM  on  in-treatment  behaviors.  Most  of
his  previous  work  has  been  carried  out  in  particular  sam-
les  of  smokers,  such  as  residential  substance  abuse  patients
Alessi  et  al.,  2008),  smokers  with  schizophrenia  (Tidey
t  al.,  2011),  pregnant  women  (Higgins  et  al.,  2006;  Higgins
t  al.,  2004;  Higgins  et  al.,  2012),  methadone-maintained
atients  (Dunn  et  al.,  2008)  or  low-income  patients  (Volpp
t  al.,  2006).  In  addition,  the  generalizability  of  results  is
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l2  
imited  due  to  the  small  sample  sizes  of  previous  studies
Alessi  et  al.,  2004;  Alessi  et  al.,  2008;  Dunn  et  al.,  2008;
eil  et  al.,  2004)  or  the  fact  that  samples  were  composed
f  patients  without  plans  to  quit  (Alessi  et  al.,  2004;  Chivers
t  al.,  2008;  Heil  et  al.,  2004;  Lamb  et  al.,  2007;  Lussier
t  al.,  2005;  Romanowich  &  Lamb,  2010a;  Yoon  et  al.,  2009).
urthermore,  most  of  the  studies  did  not  include  a  control
roup  (Romanowich  &  Lamb,  2010b)  or  they  compared  a  CM
ondition  with  another  one  that  also  provided  incentives
Alessi  et  al.,  2004;  Dunn  et  al.,  2008;  Heil  et  al.,  2004;
iggins  et  al.,  2004;  Lamb  et  al.,  2004;  Lamb  et  al.,  2007;
ussier  et  al.,  2005;  Romanowich  &  Lamb,  2010a;  Tidey
t  al.,  2011).  Finally,  previous  studies  have  focused  either
n  retention  or  early  abstinence  and  have  not  analyzed  the
ffect  of  CM  on  other  in-treatment  behaviors,  such  as  car-
on  monoxide  (CO)  or  cotinine  monitoring,  which  could  also
e  related  to  long-term  success  of  smoking  cessation  treat-
ents.
In  this  study,  we  combined  two  different  CM  protocols
ith  group-based  Cognitive-Behavioral  Treatment  (CBT).
he  ﬁrst  CM  protocol  delivered  incentives  contingent  upon
moking  abstinence.  The  second  protocol  delivered  incen-
ives  contingent  upon  gradual  reductions  in  cotinine  levels.
espite  the  fact  that  previous  studies  suggest  that  shap-
ng  procedures  may  help  individuals  to  achieve  abstinence
Lamb  et  al.,  2004;  Romanowich  &  Lamb,  2010a),  this  sched-
le  of  incentive  delivery  merits  further  investigation,  since
he  evidence  is  still  scarce.  The  aims  of  the  present  study
ere:  (1)  to  assess  whether  adding  two  different  CM  pro-
ocols  to  CBT  improved  the  main  in-treatment  variables
hat  the  literature  has  shown  to  predict  long-term  smoking
bstinence;  and  (2)  to  analyze  the  effect  of  these  in-
reatment  variables  on  patients’  smoking  status  (abstinent
ersus  smoker)  at  a  6-month  follow-up  among  treatment-
eeking  patients  in  a  community  setting.
ethod
articipants
his  study  was  developed  at  the  Addictive  Behaviors  Clinic
f  the  University  of  Oviedo  (Spain).  Participants  were
reatment-seeking  smokers  from  the  general  population.
nclusion  criteria  for  the  study  were  being  aged  over  18,
eeting  the  diagnostic  criteria  for  nicotine  dependence
ccording  to  the  Diagnostic  and  Statistical  Manual  of  Men-
al  Disorders  (fourth  ed.,  text  rev.;  DSM--IV--TR;  American
sychiatric  Association,  2000)  assessed  using  the  Structured
linical  Interview  for  DSM-IV  (SCID),  having  smoked  10  or
ore  cigarettes  per  day  for  the  previous  12  months,  and
e  willing  to  attend  to  the  clinic  twice  a  week.  We  excluded
atients  who  displayed  a  severe  psychiatric  disorder  (includ-
ng  substance  use  disorder)  or  who  were  receiving  any  other
moking  cessation  treatment.
In  order  to  report  this  randomized  controlled  trial  (RCT)
ccording  to  international  standards,  we  followed  the  Con-
olidated  Standards  of  Reporting  Trials  (CONSORT)  (Moher
t  al.,  2012).  Participants  provided  informed  consent,  and
he  procedures  followed  were  in  accordance  with  the  eth-
cal  standards  of  the  institution.  An  a  priori  power  analysis
sing  G*Power  3.1  (Faul,  Erdfelder,  Lang,  &  Buchner,  2007)
s
c
r
tC.  López-Nún˜ez  et  al.
as  computed  to  ensure  sufﬁcient  power  (≥  80%)  for  testing
he  aims  of  the  present  study.  Out  of  a  total  of  176  peo-
le  screened,  154  (38.3%  men  and  61.7%  women)  met  the
nclusion  criteria  and  were  enrolled  in  the  study  (Figure  1).
he  mean  age  was  44.58  years  (SD  =  12.64),  the  mean  num-
er  of  cigarettes  smoked  per  day  at  intake  was  21.10
SD  =  8.52)  and  mean  score  on  the  Fagerström  Test  for  Nico-
ine  Dependence  (FTND)  (Heatherton,  Kozlowski,  Frecker,  &
agerstrom,  1991) was  5.53  (SD  =  1.91).
Eligible  participants  were  randomly  assigned  to  a  CBT
roup  (N  =  48),  to  a  CBT  plus  CM  for  Abstinence  (CMA)  group
N  =  51)  or  to  a  CBT  plus  CM  for  Shaping  cessation  (CMS)  group
N  =  55),  according  to  a  computer-generated  randomization
ist.  There  were  no  signiﬁcant  differences  (p<.05)  in  base-
ine  characteristics  between  the  three  groups  (Table  1).  The
election  process  is  described  in  a  ﬂow  chart  (Figure  1),  as
ecommended  by  Hartley  (2012).
nstruments  and  variables
uring  the  intake  session,  which  lasted  for  approximately
ne  and  a  half  hours,  the  participants’  clinical  history
as  obtained  in  order  to  gather  data  on  sociodemographic
nd  smoking-related  characteristics.  The  FTND  was  used
o  assess  nicotine  dependence,  in  addition  to  the  DSM-
V-TR  criteria.  Participants  also  provided  a  baseline  CO
ample  in  expired  air  using  a  Micro  Smokerlyzer  (Bedfont
cientiﬁc  Ltd.,  Rochester,  UK)  for  objective  veriﬁcation  of
elf-reported  smoking  status.  The  Micro  Smokerlyzer  has
n  accuracy  level  of  ±  2  parts  per  million  (ppm)  or  ±  2%.  A
S-120  chemistry  analyzer  (Shenzhen  Mindray  Bio-medical
lectronics  Co.  Ltd.,  Shenzhen,  P.  R.  China)  designed  for
n  vitro  determination  of  clinical  chemistries  was  used  to
etermine  semi-quantitative  urine  cotinine  levels  through
 homogeneous  enzyme  immunoassay  system.  According  to
he  Technical  Service  of  Quality  Control  at  Spinreact  (Spin-
eact  SAU,  St.  Esteve  d’en  Bas,  Girona,  Spain),  precision
f  analysis  includes  a  between-day  coefﬁcient  of  varia-
ion  from  5.2%  to  7.6%  at  values  equal  to  or  less  than
25  nanograms  per  milliliter  (ng/ml).  Concerning  speciﬁcity,
arious  potentially  interfering  substances  were  found  to
e  non  cross-reacting  with  the  analyses  (list  is  not  shown
ut  is  available  upon  request).  All  cotinine  specimens  were
btained  under  direct  supervision  by  a same-gender  staff
ember  and  measured  immediately.
With  the  aim  of  assessing  the  effect  of  the  treatments
n  in-treatment  behavior,  the  following  outcome  variables
ere  analyzed:  treatment  retention,  in-treatment  smoking
bstinence  and  weekly  decrease  of  cotinine  levels.  Treat-
ent  retention  was  assessed  as  the  number  of  sessions
he  participants  attended  during  the  6  weeks  of  treatment
from  1  to  11  sessions:  6  CBT  therapy  sessions  plus  5  ses-
ions  to  collect  CO  and  cotinine  specimens).  In-treatment
moking  abstinence  was  deﬁned  as  the  total  number  of  days
ithout  smoking  during  treatment  until  end-of-treatment
from  zero  to  36  days).  The  weekly  decrease  of  cotinine
evels  was  assessed  taking  into  account  the  number  of
essions  (from  1  to  11)  in  which  patients  met  the  speciﬁed
otinine  level  criteria  (participants  were  aware  of  a  weekly
eduction  goal  from  the  beginning  of  treatment).  From
he  ﬁrst  to  the  fourth  week,  a  weekly  reduction  of  30%  of
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Assessed for eligibility
(n=176)  
Excluded (n=22)
Active drug abuse or dependence (n=3)
Severe psychiatric disorders (n=7)
Did not start the treatment (n=8)
Unavailable to attend the clinic twice a week (n=2)
Medical problems (n=1)
Did not meet dependence criteria (n=1)
 
Randomized (n=154)
Intake assessment (n=51)
Reached for six-month follow-up (n=46)
Intake assessment (n=55)
Reached for six-month follow-up (n=53)
Intake assessment (n=48)
Reached for six-month follow-up (n=39)
Assigned to CBT plus CMA
(n=51)
 
Assigned to CBT
(n=48) 
Assigned to CBT plus CMS
(n=55)
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nicotine  intake  (validated  by  the  corresponding  decrease  of
cotinine  levels)  was  required  for  all  groups.  From  the  ﬁfth
session  onward,  specimens  collected  should  test  negative
for  cotinine.  Agreement  was  needed  between  cotinine  and
CO  measurements,  and  self-report.
In-treatment  smoking  abstinence  and  weekly  decrease  of
cotinine  levels  provide  complementary  information  about
participants’  smoking  status  throughout  the  treatment.  The
ﬁrst  variable  refers  exclusively  to  the  number  of  days
patients  maintain  abstinence,  while  decrease  of  cotinine
levels  also  measure  adherence  to  treatment.  Therefore,  the
patient  could  meet  the  scheduled  cotinine  criteria  and  still
continue  smoking.
In  order  to  describe  the  predictive  value  of  in-treatment
behavior  on  patients’  long-term  smoking  status,  the  out-
come  variable  analyzed  was  abstinence  at  the  6-month
follow-up  (deﬁned  as  abstinence  for  a  minimum  of  seven
days  before  the  assessment)  (Cavallo  et  al.,  2007).  Self-
reported  abstinence  was  validated  by  a negative  result
of  CO  (equal  to  or  less  than  4  ppm)  and  a  negative  urine
C
T
i
Table  1  Sample  characteristics.
CBT  (n  =  48)  CBT
Age  (years) a 46.60  ±  12.19  44.
Gender (%  women)  60.40  64.
Cigarettes per  day a 21.9  ±  8.54  21.
Years of  regular  smoking a 26.29  ±  11.73  25.
FTND score a 5.75  ±  1.89  5.
CO (ppm)  15.69  ±  7.29  14.
Note. a = Means ± SD; CBT = Cognitive-Behavioral Treatment; CMA = Co
Abstinence; CMS = Cognitive-Behavioral Treatment plus Contingency M
Nicotine Dependence; CO (ppm) = carbon monoxide (parts per million).ts  Flow  Diagram.
otinine  test  (equal  to  or  less  than  80  ng/ml).  Agreement
etween  all  three  measures  was  required.
reatment  interventions
herapists  were  members  of  the  staff  at  the  institution,  who
ere  all  masters-level  psychologists  with  previous  intensive
raining  in  the  speciﬁc  protocols.  Each  therapist  practiced
ith  two  or  three  training  cases  before  treating  any  study
articipant.  To  ensure  the  therapists’  adherence  to  the  pro-
ocols  and  competence  in  implementing  the  techniques,
ll  sessions  were  audio-recorded  and  there  was  a  one-hour
eekly  supervision  session  for  the  entire  duration  of  the
reatment  program.ognitive-Behavioral  Treatment  (CBT)
his  consisted  of  an  intervention  based  on  previous  stud-
es  (Becon˜a &  Vázquez,  1997;  Secades-Villa,  Alonso-Pérez,
 +  CMA  (n  =  51)  CBT  +  CMS  (n  =  55)  p
02  ±  12.20  43.33  ±  13.41  .395
70  60  .863
63  ±  8.79  19.91  ±  8.26  .432
20  ±  11.76  25.31  ±  13.20  .888
67  ±  1.76  5.20  ±  2.04  .282
73  ±  6.28  17.87  ±  8.93  .096
gnitive-Behavioral Treatment plus Contingency Management for
anagement for Shaping cessation; FTND = Fagerström Test for
3G
m
s
o
h
b
a
g
i
ﬁ
s
l
c
a
c
g
w
s
s
e
i
i
n
a
C
T
t
c
c
t
s
t
w
f
c
p
a
t
e
t
e
q
r
u
i
e
o
C
e
e
r
C
u
c
o
t
u
t
p
a
t
a
e
l
g
c
a
C
P
C
p
s
a
T
s
t
ﬁ
t
c
l
e
a
b
s
p
t
e
m
1
n
t
r
p
D
V
r
C
c
g
v
A
o
p
a
a
l
i
s
a
a
t
m4  
arcía-Rodríguez,  &  Fernández-Hermida,  2009),  imple-
ented  in  group-based  sessions  of  ﬁve  or  six  patients.  Each
ession  took  about  one  hour  and  was  carried  out  once  a week
ver  6  weeks.  The  components  of  the  CBT  program  were
ighly  structured  and  included:  information  about  tobacco,
ehavioral  contract  through  which  the  patients  pledged  to
ttend  the  sessions  and  quit  smoking,  self-monitoring  and
raphical  representation  of  cigarette  smoking,  nicotine  fad-
ng  (a  weekly  reduction  of  30%  of  nicotine  intake  from  the
rst  to  the  fourth  week,  and  abstinence  from  the  ﬁfth
ession  onwards),  stimulus  control,  strategies  for  control-
ing  nicotine  withdrawal  symptoms,  physiological  feedback
onsumption  (measured  by  CO  and  cotinine),  training  in
lternative  behaviors,  social  reinforcement  of  objectives
ompletion  and  abstinence,  and  relapse  prevention  strate-
ies.  CO  and  cotinine  specimens  were  collected  twice  a
eek.  One  of  the  measures  coincided  with  the  weekly  CBT
ession  and  the  other  was  scheduled  midweek  between
essions.  A  total  of  eleven  samples  were  collected  for
ach  participant  during  the  treatment.  Participants  were
nformed  of  their  CO  level  and  urinalysis  results  (cotinine)
mmediately  after  submitting  their  specimens,  but  received
o  type  of  reward  in  exchange  for  achieving  or  maintaining
bstinence.
BT  plus  CM  for  Abstinence  (CMA)
he  CBT  plus  CMA  was  provided  as  in  the  above  CBT  condi-
ion,  but  with  the  addition  of  a  CM  procedure.  CO  and
otinine  samples  were  collected  in  accordance  with  the  pro-
edure  explained  above.  The  number  of  sessions  (6  CBT
herapy  sessions  plus  5  sessions  to  collect  CO  and  cotinine
pecimens)  was  also  the  same  as  in  the  previous  condi-
ion.  The  CM  protocol  included  a  vouchers  program  through
hich  smoking  abstinence  was  reinforced.  In  order  to  rein-
orce  patients’  behavior,  we  checked  cotinine  specimens
ollected  in  the  ﬁfth  CBT  session  (the  ﬁrst  session  after  the
atient  was  required  to  be  abstinent),  between  the  ﬁfth
nd  sixth  CBT  sessions  and  in  the  sixth  CBT  session.  Par-
icipants  that  tested  negative  for  cotinine  earned  points
xchangeable  for  rewards  on  a  schedule  of  escalating  magni-
ude  of  reinforcement  (the  ﬁrst  cotinine-negative  specimen
arned  80  points,  with  a  20-point  increase  for  each  subse-
uent  and  consecutive  cotinine-negative  specimen)  with  a
eset  contingency  (i.e.,  cotinine-positive  specimens  or  fail-
re  to  submit  a  scheduled  specimen  set  the  value  back  to  the
nitial  80  points).  It  is  noteworthy  that  this  protocol  deliv-
red  rewards  contingent  upon  smoking  abstinence  and  not
nly  for  attending  the  scheduled  appointments.  In  the  ﬁfth
BT  session  a  negative  urine  cotinine  result  was  deﬁned  as
qual  to  or  less  than  80  ng/ml  in  order  to  avoid  residual
ffects.  With  the  aim  of  ensuring  that  rewards  worked  as
einforcers  for  participants’  behavior,  a  negative  result  of
O  and  self-reported  abstinence  were  also  required.  Fail-
re  to  submit  a  urine  specimen  as  scheduled  rendered  it
otinine  positive  unless  the  patient  provided  some  sort  of
fﬁcial  justiﬁcation  (job-related  or  medical)  and  attended
he  clinic  the  following  day  to  submit  a  specimen.  The  sched-
le  of  reward  delivery  did  not  allow  participants  to  return
o  the  value  they  had  obtained  prior  to  the  reset.  However,
oints  could  not  be  lost  once  earned.  Points  were  frequently
p
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ccumulated  throughout  the  treatment  and  exchanged  at
he  end  of  the  program  (sixth  CBT  session).  The  maximum
mount  that  patients  could  earn  was  300  points,  which  were
xchangeable  for  rewards  with  a  variety  of  uses,  including
eisure  activities,  cinema,  theatre,  museums,  sports  events,
yms,  adventure  sports,  meals  in  restaurants,  training,  pur-
hases  in  department  stores,  bookshops,  clothes  shops  and
rt  shops,  and  spa  and  beauty  services.
BT  plus  CM  for  Shaping  Cessation  (CMS)
atients  in  this  group  received  the  same  treatment  as  the
BT  plus  CMA  group,  with  just  one  difference.  The  CMS
rocedure  reinforced  both  the  closer  approximations  to
moking  abstinence  (from  the  ﬁrst  to  the  fourth  session)
nd  smoking  abstinence  (from  the  ﬁfth  session  onward).
he  specimens  collected  from  the  ﬁrst  to  the  fourth  ses-
ion  that  tested  progressive  reductions  in  cotinine  according
o  an  individualized  percentile  schedule  earned  points.  The
rst  weekly  reduction  of  30%  of  nicotine  intake  (checked  at
he  session  between  the  ﬁrst  and  second  CBT  sessions  and
orroborated  by  a comparable  reduction  in  urine  cotinine
evels)  earned  12  points,  with  a  4-point  increase  for  both
ach  subsequent  nicotine  reduction  of  30%  and  abstinence
fter  the  ﬁfth  CBT  session  (a  maximum  of  300  points  could
e  earned).  As  explained  above,  failure  to  submit  a  urine
pecimen  as  scheduled  rendered  it  cotinine  positive  if  the
atient  did  not  provide  ofﬁcial  justiﬁcation  or  did  not  attend
he  clinic  the  following  day.  Points  could  not  be  lost  once
arned,  but  cotinine-positive  specimens  or  failure  to  sub-
it  a  scheduled  specimen  set  the  value  back  to  the  initial
2  points.  However,  submission  of  two  consecutive  cotinine-
egative  specimens  returned  the  value  to  its  level  before
he  reset.  Points  were  exchangeable  for  the  same  type  of
ewards  that  were  available  for  patients  included  in  the  CBT
lus  CMA  group.
ata  analyses
arious  descriptive  and  frequency  analyses  were  car-
ied  out  with  regard  to  the  participants’  characteristics.
omparisons  between  the  treatment  groups  for  baseline
haracteristics  were  performed  using  a  one-way  between-
roups  analysis  of  variance  (ANOVA)  for  the  continuous
ariables  and  the  2 test  for  the  dichotomous  variables.  An
NOVA  was  performed  in  order  to  assess  the  effect  of  CM
n  the  in-treatment  behavior.  Effect  sizes  of  principal  com-
arisons  were  calculated  using  eta  squared  (2),  taking  into
ccount  values  for  small,  medium  and  large  effects  (.01,  .06
nd  .14)  (Cohen,  1988).  Discriminant  analyses  were  calcu-
ated  with  the  aim  of  analyzing  the  predictive  value  of  the
n-treatment  variables  (treatment  retention,  in-treatment
moking  abstinence  and  weekly  decrease  of  cotinine  levels)
ffecting  the  patients’  condition  (abstinent  versus  smoker)
t  a  follow-up  assessment  6  months  after  treatment  comple-
ion.  The  outcomes  are  reported  in  two  ways,  one  in  which
issing  urine  samples  at  6-month  follow-up  were  considered
ositive  (following  an  intent-to-treat  approach)  and  a  sec-
nd  one  in  which  missing  samples  were  considered  as  missing
ata.  The  conﬁdence  level  was  95%,  and  the  statistical  pack-
ge  used  was  the  SPSS  (V19;  SPSS,  Inc.,  Chicago,  IL).
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Figure  2  In-treatment  outcomes  over  the  6-week  interven-
tion.
Note. CBT  =  Cognitive-Behavioral  Treatment;  CBT  +  CMA  =
Cognitive-Behavioral  Treatment  plus  Contingency  Management
for Abstinence;  CBT  +  CMS  =  Cognitive-Behavioral  Treatment
plus CM  for  Shaping  cessation.
Table  2  Correlations  of  each  in-treatment  variable  with
each discriminative  function  (Structure  Matrix)a.
Function
1
Missing  positive
(n  =  154)
Missing  missing
(n =  138)
Total  number  of  days
without  smoking
during  the
treatment
.94  .93
Number  of  days  of
weekly  reduction  of
cotinine
.81  .82
Number  of  sessions
attended
.36  .34
a = Pooled within-groups correlations between discriminating
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Treatment  retention
There  was  a  statistically  signiﬁcant  difference  in  treat-
ment  retention  for  the  three  conditions  (F  (2,  151)  =  13.04,
p  <  .01).  The  mean  number  of  sessions  attended  among
patients  included  in  the  CBT  group  (M  =  9.29;  SD  =  3.23)
was  signiﬁcantly  lower  than  the  mean  number  of  sessions
attended  in  the  CBT  plus  CMA  group  (M  =  10.86;  SD  =  0.53;
p  <  .01)  and  in  the  CBT  plus  CMS  group  (M  =  10.96;  SD  =  0.19;
p  <  .01).  CBT  plus  CMA  did  not  differ  signiﬁcantly  from  CBT
plus  CMS  (p  =  .957).  Despite  the  fact  that  the  data  hardly
differ  among  the  three  groups,  the  magnitude  of  the  dif-
ferences  in  the  number  of  sessions  was  large  (2 =  .15).  The
week-by-week  progression  of  treatment  retention  outcomes
is  shown  in  Figure  2.
6
A
tvariables and standardized canonical discriminant functions.
Variables ordered by absolute size of correlation within function.
n-treatment  smoking  abstinence
 statistically  signiﬁcant  difference  was  found  for  in-
reatment  smoking  abstinence  for  the  three  groups  (F  (2,
51)  =  15.46,  p  <  .01).  The  mean  number  of  days  without
moking  during  the  treatment  achieved  by  participants  in
BT  group  (M  =  6.67;  SD  =  6.77)  was  signiﬁcantly  lower  than
he  mean  days  of  abstinence  achieved  by  patients  included
n  both  the  CBT  plus  CMA  (M  =  11.59;  SD  =  5.84;  p  <  .01)  and
BT  plus  CMS  (M  =  12.84;  SD  = 5.01;  p  <  .01)  groups.  No  statis-
ically  signiﬁcant  differences  were  found  between  the  CBT
lus  CMA  and  CBT  plus  CMS  (p  =  .520)  groups.  The  magnitude
f  the  differences  in  the  total  number  of  days  of  absti-
ence  was  large  (2 =  .17).  The  week-by-week  progression
f  in-treatment  smoking  abstinence  outcomes  is  shown  in
igure  2.
eekly  decrease  of  cotinine  levels
here  were  statistically  signiﬁcant  differences  among  treat-
ent  groups  in  the  number  of  sessions  of  weekly  reduction
f  cotinine  (F  (2,  137)  =  22.94,  p  <  .01).  Participants  included
n  the  CBT  group  achieved  the  scheduled  weekly  reduction
f  cotinine  with  fewer  sessions  (M  =  6.28;  SD  =  3.71)  than
atients  in  the  CBT  plus  CMA  group  (M  =  8.38;  SD  =  2.76;
 =  .002)  and  patients  in  the  CBT  plus  CMS  group  (M  =  10.11;
D  =  1.65;  p  <  .01).  Statistically  signiﬁcant  differences  were
lso  found  between  CBT  plus  CMA  and  CBT  plus  CMS
p  =  .005).  The  magnitude  of  the  differences  in  the  weekly
eduction  of  cotinine  was  large  (2 =  .25).  Figure  2  shows
he  week-by-week  progression  of  the  number  of  sessions  in
hich  patients  met  the  weekly  decrease  of  cotinine  levels.
redictive  value  of  the  in-treatment  variables  at
-month  follow-up
nalysis  of  the  structure  matrix  (Table  2) indicates  the  rela-
ive  importance  of  the  predictors,  showing  the  correlations
36  C.  López-Nún˜ez  et  al.
Table  3  Percentage  of  smokers  classiﬁed  correctly  into  abstinent  or  smoker  groups  (Classiﬁcation  Results) a.
Missing  positive b Missing  missing c
Condition  at  six-
month  follow-up
Abstinent  Smoker  Total  Abstinent  Smoker  Total
Original  Count  Abstinent  17  36  53  18  35  53
Smoker 14  87  101  14  71  85
Unclassiﬁed  -  -  -  0  16  16
% Abstinent  32.1  67.9  100  34  66  100
Smoker 13.9  86.1  100  16.5  83.5  100
Unclassiﬁed  -  -  -  0  100  100
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fa = Intent-to-treat analysis; b = Correctly classiﬁed 67.5% of origina
f  each  variable  with  each  discriminative  function.  Both
iscriminant  analyses  (missing  urine  samples  at  6-month
ollow-up  as  positive  and  as  missing  data)  revealed  that  in-
reatment  smoking  abstinence  (total  number  of  days  without
moking  during  the  treatment)  is  the  best  predictor  of  long-
erm  abstinence  (.94  and  .93,  respectively).
The  classiﬁcation  results  (Table  3)  show  that  67.5%  of
espondents  for  whom  statistical  analyses  were  conducted
ncluding  missing  urine  samples  at  the  6-month  follow-up
s  positive  results  (missing  as  positive)  were  classiﬁed  cor-
ectly  into  abstinent  or  smoker  groups.  Classiﬁcation  results
lso  show  that  64.5%  of  respondents  for  whom  missing  urine
amples  at  the  6-month  follow-up  were  not  included  in
he  statistical  analysis  (missing  as  missing)  were  classiﬁed
orrectly  in  both  groups.  Overall,  16  participants  failed  to
rovide  urine  samples  at  the  6-month  follow-up  assessment
CBT  = 9,  CBT  plus  CMA  =  5  and  CBT  plus  CMS  =  2).  Considering
he  ﬁrst  approach,  smokers  were  classiﬁed  with  better  accu-
acy  (86.1%)  than  abstainers  (32.1%).  The  second  approach
lso  showed  the  same  results  (83.5%  of  smokers  were  cor-
ectly  classiﬁed  vs.  34%  of  abstainers).
iscussion
he  goals  of  the  present  study  were  to  analyze  whether
dding  two  different  CM  procedures  to  CBT  improved  three
n-treatment  behaviors  (treatment  retention,  in-treatment
moking  abstinence  and  weekly  decrease  of  cotinine  levels)
nd  to  identify  the  predictive  effect  of  these  in-treatment
ehaviors  on  smoking  abstinence  at  long-term  follow-up.
he  results  showed  that  both  CM  protocols  improved  the
hree  in-treatment  behaviors  and  that  these  in-treatment
ehaviors  (particularly  in-treatment  smoking  abstinence)
ere  associated  with  smoking  abstinence  at  6-month  follow-
p.
Both  CM  procedures  (reinforcing  smoking  abstinence  and
loser  approximations  to  smoking  abstinence)  improved
reatment  retention,  in-treatment  smoking  abstinence  and
eekly  decreased  of  cotinine  levels  in  comparison  with  CBT
lone.  In  particular,  the  number  of  days  abstinent  at  the  end-
f-treatment  in  both  CBT  +  CM  groups  was  almost  double  the
gure  for  the  CBT  alone  group.  It  is  noteworthy  that  despite
ewards  in  CMA  group  being  contingent  on  smoking  absti-
ence  at  the  end-of-treatment,  this  protocol  also  improved
n-treatment  behaviors.  It  seems  that  rewards  increased
l
i
t
pped cases; c = Correctly classiﬁed 64.5% of original grouped cases.
otivation  to  change  (Higgins  et  al.,  2008)  and  due  to  this,
einforced  the  in-treatment  behaviors  among  participants
n  their  alignment  with  the  target  behavior  (weekly  reduc-
ions  of  nicotine  and  abstinence  at  the  end  of  the  treatment)
Lamb  et  al.,  2004).  The  description  of  future  consequences
an  inﬂuence  current  behavior  when  they  are  stated  verbally
Strathman,  Gleicher,  Boninger,  &  Edwards,  1994).  In  this
roup,  the  expectation  of  reinforcement  at  the  end  of  the
reatment  may  shape  participants’  behavior  before  reaching
bstinence;  in  other  words,  in-treatment  behaviors  (partic-
larly  in-treatment  smoking  abstinence)  could  be  analyzed
s  conditioned  responses  governed  by  the  ﬁnal  reinforce-
ent  at  end-of-treatment,  which  is  indeed  derived  from
ompliance  with  such  in-treatment  behaviors  (Chivers  et  al.,
008).
It  is  noteworthy  that,  comparing  CBT  alone  to  the  two
roups  with  CM  added,  the  number  of  days  abstinent  during
he  treatment  differed  by  5  to  6  days.  We  believe  this  result
s  clinically  meaningful  taking  into  consideration  the  inﬂu-
nce  of  early  abstinence  over  long-term  success  (Heil  et  al.,
004).
Despite  the  effectiveness  of  CM  to  improve  the  treat-
ent  behaviors,  adding  a  CM  protocol  to  standard  care  leads
o  an  increase  in  costs,  which  could  be  an  obstacle  to  the
xpansion  of  this  program  in  community  settings.  Future
tudies  should  investigate  the  cost-effectiveness  of  such
n  evidence-based  CM  protocol  in  representative  settings
nd  populations  in  order  to  make  policy  decisions  about  CM
mplementation  for  smoking  cessation  in  the  broader  com-
unity.
The  in-treatment  behaviors  (particularly  in-treatment
moking  abstinence)  were  associated  with  patients’  smoking
tatus  at  a  6-month  follow-up.  In  accordance  with  previous
esearch,  in-treatment  abstinence  (Alessi  et  al.,  2004;  Heil
t  al.,  2004;  Higgins  et  al.,  2006;  Lamb  et  al.,  2004;  Yoon
t  al.,  2009) and  treatment  retention  (Dorner  et  al.,  2011)
redicted  better  long-term  abstinence  outcomes.
Participants  who  adhered  to  the  scheduled  weekly
ecrease  of  cotinine  levels  during  the  treatment  also
chieved  better  results  at  6-month  follow-up.  However,  to
ur  knowledge,  no  previous  study  has  compared  the  dif-
erential  effect  of  these  three  in-treatment  behaviors  on
ong-term  abstinence  in  a  smoking  cessation  program  that
ncludes  treatment-seeking  patients  in  a  community  set-
ing.  Our  results  extend  previous  ﬁndings  by  indicating  that
articularly  the  factors  related  to  early  abstinence  (total
eha
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number  of  days  without  smoking  during  the  treatment  and
weekly  decrease  of  cotinine  levels)  are  strongly  associated
with  abstinence  at  6-month  follow-up.
The  relationship  between  these  in-treatment  behaviors
and  long-term  abstinence  could  be  explained  as  a  conse-
quence  of  the  experimental  control  over  smoking  behavior
exerted  during  the  treatment  (Alessi  et  al.,  2004;  Chivers
et  al.,  2008).  The  fulﬁllment  of  these  in-treatment  behaviors
usually  encourages  patients  to  achieve  and  maintain  their
abstinence,  and  to  adhere  to  the  guidelines  for  quitting,
which  in  turn  reduce  both  nicotine  withdrawal  and  future
risk  of  relapse  (Alessi  et  al.,  2004;  Yoon  et  al.,  2009).
Taking  together,  these  results  suggest  that  the  in-
treatment  behaviors,  specially  early  initiation  of  absti-
nence,  should  be  crucial  goals  for  effective  smoking
cessation  treatments  in  order  to  increase  long-term  smok-
ing  abstinence  (Higgins  et  al.,  2006;  Romanowich  &  Lamb,
2010b).
Some  limitations  of  the  study  merit  mention.  Firstly,  the
study  enrolled  more  women  than  men,  which  could  limit
the  sample’s  representativeness  of  the  smoking  population.
However,  previous  research  has  shown  that  females  are
more  likely  than  males  to  attempt  to  quit  (Rafful  et  al.,
2013).  Secondly,  our  study  assesses  abstinence  at  6-month
follow-up  after  the  end  of  the  treatment.  It  would  be  use-
ful  to  evaluate  the  effect  of  the  in-treatment  variables  on
longer-term  abstinence,  for  example  at  12-month  follow-up.
On  the  other  hand,  there  was  signiﬁcant  variability  among
participants  in  the  number  of  cigarettes  smoked.  However,
our  smoking  cessation  program  established  30%  of  nicotine
reduction  for  all  patients,  so  that  weekly  nicotine  fading  was
higher  for  heavy  smokers  in  comparison  to  medium  smokers.
In  addition,  all  participants  could  earn  the  same  amount  of
rewards.  Thus,  it  would  be  interesting  to  adjust  the  require-
ment  for  accessing  rewards  taking  into  account  nicotine
fading  among  participants  with  different  pre-treatment  con-
sumption  levels.
In  spite  of  these  limitations,  our  ﬁndings  indicate  that  CM
protocols  improve  the  in-treatment  behaviors  among  smok-
ers  who  want  to  quit  and  that  these  in-treatment  behaviors
(particularly  in-treatment  smoking  abstinence)  are  associ-
ated  with  long-term  smoking  abstinence.
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